# Amylyx Pharmaceuticals, Inc.: Form DEF 14A, filed Apr 27, 2023

- Company: [Amylyx Pharmaceuticals, Inc.](/companies/amlx.md) (CIK 1658551)
- Form: DEF 14A
- Filed: 2023-04-27
- Accepted by EDGAR: Apr 27, 2023, 16:06 ET
- Period: 2023-06-08
- Accession: 0000950170-23-015261
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1658551/000095017023015261/amlx-def14a-2023-proxy.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1658551/000095017023015261/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1658551/000095017023015261/amlx-def14a-2023-proxy.htm

Filed Apr 27, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-015261. Last ingested by Listed: Nov 13, 2026, 14:43 ET. No prices; not investment advice.
